Session

Responsibly Advancing AI in Clinical Trials

As artificial intelligence (AI) rapidly transforms the landscape of clinical trials, the need for responsible implementation has never been more critical. This session will explore how AI can be harnessed to enhance clinical trial design, patient recruitment, data analysis, and outcome prediction, while ensuring ethical considerations are front and center.

We'll delve into the potential of AI to streamline trial processes, reduce costs, and accelerate the development of new therapies. However, with great power comes great responsibility. We'll discuss the challenges of bias, data privacy, transparency, and regulatory compliance, and how to address them to build trust in AI-driven methodologies.

Join us as we navigate the delicate balance between innovation and ethics, and discover best practices for integrating AI into clinical trials in a way that enhances accuracy, efficiency, and fairness. Whether you're a researcher, clinician, or industry professional, this session will provide valuable insights into the responsible advancement of AI in clinical trials, ensuring that technological progress benefits both science and society.

Nalini Garg

Senior Manager, Deloitte

San Mateo, California, United States

Actions

Please note that Sessionize is not responsible for the accuracy or validity of the data provided by speakers. If you suspect this profile to be fake or spam, please let us know.

Jump to top